Tunay ŞENTÜRK, Metin GÜÇLÜ, Bülent ÖZDEMİR, Aydın Aysel KADERLİ, Sevil GÜÇLÜ, İbrahim BARAN, Ali AYDINLAR, Sümeyye GÜLLÜLÜ

Tip ıı diyabetes mellituslu hastalarda kardiyak otonom nöropati ile diyastolik kalp fonksiyonları ilişkisi

Hem tedavi hem de prognoz açısından önemli farklılıklar gösterdiği için erken dönemde saptanan diyastolik disfonksiyon, sistolik disfonksiyona göre koruyucu hekimlik açısından daha büyük önem arz etmektedir. Bu nedenle çalışmamızda aşikâr kardiyak hastalık bulguları olmayan diyabetik hastalarda prognoz için önemli belirteçler olan kardiyak otonom nöropati (KON) ile diyastolik disfonksiyonun ilişkisini araştırdık. Çalışmaya tip 2 diabetes mellitus tanısı olan 33 hasta dahil edildi. Sağlıklı yaş uyumlu 12 kişi kontrol grubu olarak alındı. KON Ewing testi ile, diyastolik kalp fonksiyonları ekokardiyografi ile değerlendirildi. Ewing skoru

The relationship between cardiac autonomic neuropathy and diastolic heart function in patients with type ıı diabetes mellitus

Since it shows important differences in circumstances of treatment and prognosis the early diagnosed diastolic dysfunction, compared to systolic dysfunction presents much more importance in terms of preventive practice. In this study we examined the association of cardiac autonomic neuropathy (CAN) and diastolic dysfunction that are important predictors for prognosis in diabetic patients who do not have findings of obvious cardiac disease. In the study 33 patients with type 2 diabetes mellitus were enrolled. Healthy 12 persons were taken as the control group. CAN was evaluated with Ewing test and the diastolic heart functions were evaluated with echocardiographic examination. Group 1 constituted 15 CAN (-) people with Ewing score

PDF

___

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-31.
2. Boyl JP, Honeycut AA, Narayan KM et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the US. Diabetes Care 2001; 24: 1936 – 40.
3. McGuire DK, Rao SV. Epidemiology of diabetes mellitus and cardiovascular disease In: Handbook of Diabetes mellitus and Cardiovascular Disease Marso S.P (eds) 1.Edition Remedica Publising Limited 2003 1 -24.
4. Masharani U, Karam JH., German SM, Chronic Complications of Diabetes Mellitus In: Greenspan FS, Gardner DG (eds) Basic& Clinical Endocrinology 7th Edition Lange Medical Books/McGraw Hill Companies; 2004 723 – 32.
5. American Diabetes Association. Consensus Development Conference on the diagnosis of coronary heart disease in the people with diabetes. Diabetes Care 1998; 21: 1551 – 59. 6. Maser R., Pfeifer M., Dorman J., Diabetic autonomic neuropathy and cardiovascular risk. Arch Int Med. 1990; 150: 1218 - 22.
7. Vinik A.I, Zola B.E. Diabetik otonom nöropatinin kardiyovasküler sistem üzerine etkileri In: Diabetes mellitus veKardiyovasküler Hastalıklarda Yeni Ufuklar (New Horizons in Diabetes Mellitus & Cardiovascular Disease) Çvr editör Oğuz A., (Eds. Schwartz C.J., Born G.V.R Current Science 1995 London) CSA yayınevi İstanbul 1999 169-79.
8. Yeşil S. Diyabetik Nöropati ve Tedavisi. Endokrinoloji (Diabetes Mellitus Özel Sayısı) 2003; 1 (3); 232–36. 9. Singh N. Diabetes, Heart Rate, and Mortality. J Cardiovasc Pharmacol Therapeut 2002; 7: 117-29.
10. Vinik AI, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies Diabetologia 2000; 43; 957-73.
11. Tomlinson DR., Fernyhough P, Diemel LT, Stevens EJ. New Horizons in Diabetes Mellitus & Cardiovascular Disease. Eds. Schwartz C.J., Born G.V.R Current Science 1995 London 182-93.
12. Vinik A.I, Erbaş T., Recognizing and treating diabetic neuropathy Cleveland Clinic Journal of Medicine 2001; 68(11): 928-44.
13. Bloomgarden Z.T. Cardiovascular Disease in Type 2 Diabetes. Diabetes Care. 1999; 22 (10): 1739 - 44.
14. Devereux RB, Roman MJ, Paranicas M,. O’Grady MJ, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER,. Howard BV: Impact of Diabetes on Cardiac Structure and Function The Strong Heart Study Circulation. 2000; 101: 2271-76.
15. Singh JP, Larson MG, O’Donnell CJ, Wilson PF, Tsuji H, Lloyd-Jones DM, Levy D, Association of Hyperglycemia With Reduced Heart Rate Variability (The Framingham Heart Study) Am J Cardiol 2000; 86: 309-12.
16. Hilsted J, Galbo H, Christensen NJ, Parving HH, Benn J. Haemodynamic changes during graded exercise in patients with diabetic autonomic neuropathy. Diabetologia 1982; 22: 318–23.
17. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Cardiovasc Drugs Ther 1994; 8: 65–73.
18. Piccini J.P., Klein L., Gheorghiade M., Bonow R.O., New Insight into Diastolic Heart Failure: Role of Diabetes Mellitus Am J Med 2004; 116(5A) 64S-75S.
19. Taskiran M, Rasmussen V, Rasmussen B, Fritz-Hansen T, Larsson HB, Jensen GB,Hilsted J Left ventricular dysfunction in normotensive Type 1 diabetic patients: the impact of autonomic neuropathy. Diabet Med. 2004;21:524-30.
20. Şekuri C, Kurhan Z, Tavlı T, Bayturan Ö, Ütük O, Bilge AR, Tıkız H, Tezcan UK. Akut Q-Dalgalı Miyokard İnfarktüsünde Miyokardiyal Performans İndeksi ve Mitral E Dalga Deselerasyon Zamanı Arasındaki İlişki. Anadolu Kardiyol Derg 2004; 4: 108-13.
21. Monteagudo PT, Moises VA, Kohlmann O, Ribeiro AB, Lima VC, Zanella MT. Influence of autonomic neuropathy upon left ventricular dysfunction in insulin-dependent diabetic patients. Clin Cardiol 2000; 23: 371–75.
22. Irace L, Iarussi D, Guadagno I, Tedesco MA, Perna B, Ratti G et al. Left ventricular performance and autonomic dysfunction in patients with long-term insulin-dependent diabetes mellitus. Acta Diabetol 1996; 33: 269–73.
23. Leakso M.Textbook of Type 2 Diabetes Goldstein B.J., Müler- Wieland D.(eds) 1.edition. Taylor Francis Group 2003 1- 12.
24. Coopan R. Diabetes mellitusta glikoz kontrolünün hedefleri ve mantığı ve glikoz monitarizasyonu In Textbook of Type 2 Diabetes Goldstein B.J., Müler-Wieland D.(eds) (Çvr.edt.Akman A.C).1.edition. Taylor Francis Group 2003 29-38.
25. Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer BE. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 2002;98(1-2): 33-9.